James Basta

Insider Reports History

Location
San Diego, CA
Signature
James Basta
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by James Basta:

Company Role Class Num Shares Value Price $ Report Date Ownership
Intellia Therapeutics, Inc. EVP, General Counsel Common Stock 156,794 $2,160,621 $13.78 02 Mar 2026 Direct
Intellia Therapeutics, Inc. EVP, General Counsel Stock Option (right to buy) 65,829 01 Mar 2026 Direct

Insider Reports Filed by James Basta

Symbol Company Period Transactions Value $ Form Type Role Filing Time
NTLA Intellia Therapeutics, Inc. 01 Mar 2026 3 -$16,688 4 EVP, General Counsel 03 Mar 2026, 16:18
NTLA Intellia Therapeutics, Inc. 05 Jan 2026 1 -$95,756 4 EVP, General Counsel 07 Jan 2026, 16:05
NTLA Intellia Therapeutics, Inc. 01 Mar 2025 3 -$23,122 4 EVP, General Counsel 04 Mar 2025, 16:21
NTLA Intellia Therapeutics, Inc. 03 Jan 2025 1 -$86,161 4 EVP, General Counsel 07 Jan 2025, 17:22
NTLA Intellia Therapeutics, Inc. 01 Mar 2024 3 -$75,778 4 EVP, General Counsel 05 Mar 2024, 16:10
NTLA Intellia Therapeutics, Inc. 03 Jan 2024 1 -$112,095 4 EVP, General Counsel 05 Jan 2024, 16:45
NTLA Intellia Therapeutics, Inc. 01 Mar 2023 4 -$47,741 4 EVP, General Counsel 03 Mar 2023, 16:10
NTLA Intellia Therapeutics, Inc. 04 Jan 2023 1 -$42,345 4 EVP, General Counsel 06 Jan 2023, 16:19
NTLA Intellia Therapeutics, Inc. 01 Mar 2022 1 $0 4/A EVP, General Counsel 04 Mar 2022, 20:09
NTLA Intellia Therapeutics, Inc. 01 Jul 2021 1 $0 4 EVP, General Counsel 06 Jul 2021, 16:44
NTLA Intellia Therapeutics, Inc. 23 Jun 2021 0 $0 3 EVP, General Counsel 06 Jul 2021, 16:42